|
|
|
市場調查報告書
全球胰島素幫浦市場:開發平台分析，競爭環境，到2017年為止的市場預測
Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
| 出版商 |
GlobalData |
| 出版日期 |
2011年12月 |
商品編碼 |
224429 |
| 內容資訊 |
英文 Pages: 88 |
| 價格 |
|
|
全球胰島素幫浦市場:開發平台分析，競爭環境，到2017年為止的市場預測 是由出版商GlobalData在2011年12月所出版的。
這份英文市場調查報告書包含Pages: 88 價格從美金3500起跳。
本報告提供胰島素幫浦的全球市場最新趨勢與未來展望相關分析，整體市場結構，全球的市場趨勢(2003∼2017年的市場收益的測量與預測等)，各部門·各國市場趨勢，再加上主要企業簡介，開發中的產品的開發平台評估等資訊彙整，為您概述為以下內容。
第1章 目錄
第2章 簡介·概要
第3章 疾病概要:糖尿病
- 糖尿病的種類
- 徵兆
- 診斷
- 空腹血糖(FPG)測試
- 口服葡萄糖耐受(OGTT)試驗
- 隨機血糖檢查
- 免疫學
- 美國糖尿病的流行病學
- 在英國糖尿病的流行病學
- 在日本糖尿病的流行病學
- 印度糖尿病的流行病學
- 中國糖尿病的流行病學
第4章 胰島素幫浦:設備概要
第5章 全球胰島素市場特徵
- 市場收益實際成果值(全球，2003∼2010年)
- 市場收益預測值(全球，2010∼2017年)
- 全球胰島素幫浦市場主要趨勢
- 美國胰島素幫浦的市場普及率高於歐洲
- FDA（食品藥物管理局）預計將強化施打幫浦的法規
- 胰島素幫浦與血糖監測器/動態血糖監測器的共同行銷，是近來市場趨勢
- 人工胰臟將成為今後胰島素幫浦市場趨勢
- 市場動態
第6章 各部門分析
- 傳統胰島素幫浦:市場收益實際成果值(全球，2003∼2010年)
- 傳統胰島素幫浦:市場收益預測值(全球，2010∼2017年)
- 拋棄式型胰島素幫浦:市場收益實際成果值(全球，2003∼2010年)
- 拋棄式型胰島素幫浦:市場收益預測值(全球，2010∼2017年)
第7章 各國分析與預測
- 市場收益實際成果值(美國，2003∼2010年)
- 市場收益預測值(美國，2010∼2017年)
- 市場收益實際成果值(加拿大，2003∼2010年)
- 市場收益預測值(加拿大，2010∼2017年)
- 市場收益實際成果值(英國，2003∼2010年)
- 市場收益預測值(英國，2010∼2017年)
- 市場收益實際成果值(德國，2003∼2010年)
- 市場收益預測值(德國，2010∼2017年)
- 市場收益實際成果值(法國，2003∼2010年)
- 市場收益預測值(法國，2010∼2017年)
- 市場收益實際成果值(義大利，2003∼2010年)
- 市場收益預測值(義大利，2010∼2017年)
- 市場收益實際成果值(西班牙，2003∼2010年)
- 市場收益預測值(西班牙，2010∼2017年)
- 市場收益實際成果值(日本，2003∼2010年)
- 市場收益預測值(日本，2010∼2017年)
- 市場收益實際成果值(中國，2003∼2010年)
- 市場收益預測值(中國，2010∼2017年)
- 市場收益實際成果值(印度，2003∼2010年)
- 市場收益預測值(印度，2010∼2017年)
- 市場收益實際成果值(澳洲，2003∼2010年)
- 市場收益預測值(澳洲，2010∼2017年)
- 市場收益實際成果值(巴西，2003∼2010年)
- 市場收益預測值(巴西，2010∼2017年)
第8章 競爭企業評估
- 主要企業的市場佔有率(全球，2010年)
- 主要企業(全球)
- Medtronic Inc.
- Insulet Corporation
- Roche (Disetronic Medical Systems AG)
- Animas Corporation
第9章 開發平台評估
- 胰島素幫浦的開發平台:開發不同階段(2011年)
- 開發平台評估:各開發階段(2011年)
- 主要的開發中產品
- Artificial Pancreas System (Boston University)
- Artificial Pancreas System (University of Virginia)
- Cellnovo Wireless Insulin Pump System (Cellnovo Ltd.)
- Eros Insulin Pump (Insulet Corporation)
- Jewel Pump (Debiotech S.A.)
- Minimed Model 2007 Implantable Insulin Pump (Medtronic, Inc.)
- Paradigm Veo System (Medtronic, Inc.)
- Solo MicroPump Insulin Delivery System (Roche Diagnostics GmbH)
第10章 策略性交易分析
第11章 附錄
圖表一覽
Abstract
Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Summary
GlobalData's new report, "Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global insulin pumps market. The report provides market landscape, competitive landscape and market trends information on the insulin pumps market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market's dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Disposable Insulin Pumps and Traditional Insulin Pumps.
- Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints within the insulin pumps market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Medtronic, Animas Corporation and Insulet Corporation.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the insulin pumps globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- What's the next big thing in the insulin pumps market landscape? - Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global insulin pumps market and the factors shaping it.
TOC
1 Table of Contents
1 Table of Contents 3
- 1.1 List of Tables 5
- 1.2 List of Figures 6
2 Introduction and Overview 7
- 2.1 Introduction 7
- 2.2 GlobalData Report Guidance 7
3 Disease Overview - Diabetes 8
- 3.1 Types of Diabetes 8
- 3.1.1 Type 1 diabetes 8
- 3.1.2 Type 2 diabetes 8
- 3.1.3 Gestational diabetes 8
- 3.2 Signs and Symptoms 8
- 3.3 Diagnosis 9
- 3.3.1 Fasting Plasma Glucose (FPG) Test 9
- 3.3.2 Oral Glucose Tolerance Test (OGTT) 9
- 3.3.3 Random Plasma Glucose Test 10
- 3.4 Epidemiology 10
- 3.4.1 Epidemiology of Diabetes in the US 11
- 3.4.2 Epidemiology of Diabetes in UK 11
- 3.4.3 Epidemiology of Diabetes in Japan 11
- 3.4.4 Epidemiology of Diabetes in India 11
- 3.4.5 Epidemiology of Diabetes in China 11
4 Insulin Pumps - Device Overview 12
- 4.1 Insulin Pumps, Market Segmentation 12
- 4.1.1 Traditional Insulin Pumps 12
- 4.1.2 Disposable Insulin Pumps 12
- 4.2 Comparison of Insulin Pumps with Other Insulin Delivery Devices 13
5 Insulin Pumps - Global Market Characterization 14
- 5.1 Insulin Pumps Market, Global, Revenue ($m), Historic, 2003-2010 14
- 5.2 Insulin Pumps Market, Global, Revenue ($m), Forecast, 2010-2017 15
- 5.3 Global Insulin Pumps Market, Key Trends 16
- 5.3.1 The US has a Higher Market Penetration Rate for Insulin Pumps Compared to Europe 16
- 5.3.2 FDA Plans to Tighten the Regulation of Infusion Pumps 16
- 5.3.3 Co-Marketing of Insulin Pumps with Blood Glucose Monitoring/Continuous Glucose Monitor Devices is a Recent Trend in the Market 17
- 5.3.4 Artificial Pancreas to be a Future Trend in the Insulin Pumps Market 17
- 5.4 Global Insulin Pumps, Market Dynamics 20
- 5.4.1 Market Drivers 20
- 5.4.2 Market Restraints 25
6 Global Insulin Pumps Market - Analysis by Segment 27
- 6.1 Traditional Insulin Pumps, Global, Revenue ($m), Historic, 2003-2010 27
- 6.2 Traditional Insulin Pumps, Global, Revenue ($m), Forecast, 2010-2017 28
- 6.2.1 Market Drivers 28
- 6.2.2 Market Restraints 29
- 6.3 Disposable Insulin Pumps, Global, Revenue ($m), Historic, 2005-2010 33
- 6.4 Disposable Insulin Pumps, Global, Revenue ($m), Forecast, 2010-2017 34
- 6.4.1 Market Drivers 35
- 6.4.2 Market Restraints 35
7 Global Insulin Pumps Market - Analysis and Forecasts by Country 36
- 7.1 Insulin Pumps Market, The US, Revenue ($m), Historic, 2003-2010 36
- 7.2 Insulin Pumps Market, The US, Revenue ($m), Forecast, 2010-2017 37
- 7.3 Insulin Pumps Market, Canada, Revenue ($m), Historic, 2003-2010 38
- 7.4 Insulin Pumps Market, Canada, Revenue ($m), Forecast, 2010-2017 39
- 7.5 Insulin Pumps Market, The UK, Revenue ($m), Historic, 2003-2010 40
- 7.6 Insulin Pumps Market, The UK, Revenue ($m), Forecast, 2010-2017 41
- 7.7 Insulin Pumps Market, Germany, Revenue ($m), Historic, 2003-2010 42
- 7.8 Insulin Pumps Market, Germany, Revenue ($m), Forecast, 2010-2017 43
- 7.9 Insulin Pumps Market, France, Revenue ($m), Historic, 2003-2010 44
- 7.10 Insulin Pumps Market, France, Revenue ($m), Forecast, 2010-2017 45
- 7.11 Insulin Pumps Market, Italy, Revenue ($m), Historic, 2003-2010 46
- 7.12 Insulin Pumps Market, Italy, Revenue ($m), Forecast, 2010-2017 47
- 7.13 Insulin Pumps Market, Spain, Revenue ($m), Historic, 2003-2010 48
- 7.14 Insulin Pumps Market, Spain, Revenue ($m), Forecast, 2010-2017 49
- 7.15 Insulin Pumps Market, Japan, Revenue ($m), Historic, 2003-2010 50
- 7.16 Insulin Pumps Market, Japan, Revenue ($m), Forecast, 2010-2017 51
- 7.17 Insulin Pumps Market, China, Revenue ($m), Historic, 2003-2010 52
- 7.18 Insulin Pumps Market, China, Revenue ($m), Forecast, 2010-2017 53
- 7.19 Insulin Pumps Market, India, Revenue ($m), Historic, 2003-2010 54
- 7.20 Insulin Pumps Market, India, Revenue ($m), Forecast, 2010-2017 55
- 7.21 Insulin Pumps Market, Australia, Revenue ($m), Historic, 2003-2010 56
- 7.22 Insulin Pumps Market, Australia, Revenue ($m), Forecast, 2010-2017 57
- 7.23 Insulin Pumps Market, Brazil, Revenue ($m), Historic, 2003-2010 58
- 7.24 Insulin Pumps Market, Brazil, Revenue ($m), Forecast, 2010-2017 59
8 Global Insulin Pumps Market - Competitive Assessment 60
- 8.1 Insulin Pumps Market, Global, Key Company Shares (%), 2010 60
- 8.2 Insulin Pumps Market, Global, Key Market Participants 61
- 8.2.1 Medtronic Inc. 61
- 8.2.2 Insulet Corporation 64
- 8.2.3 Roche (Disetronic Medical Systems AG) 67
- 8.2.4 Animas Corporation 68
9 Insulin Pumps - Pipeline Assessment 70
- 9.1 Insulin Pumps, Pipeline by Phase of Development, 2011 70
- 9.2 Pipeline Assessment by Developmental Stage, 2011 71
- 9.3 Key Pipeline Products 74
- 9.3.1 Artificial Pancreas System (Boston University) 74
- 9.3.2 Artificial Pancreas System (University of Virginia) 77
- 9.3.3 Cellnovo Wireless Insulin Pump System (Cellnovo Ltd.) 78
- 9.3.4 Eros Insulin Pump (Insulet Corporation) 78
- 9.3.5 Jewel Pump (Debiotech S.A.) 79
- 9.3.6 Minimed Model 2007 Implantable Insulin Pump (Medtronic, Inc.) 79
- 9.3.7 Paradigm Veo System (Medtronic, Inc.) 79
- 9.3.8 Solo MicroPump Insulin Delivery System (Roche Diagnostics GmbH) 80
10 Global Insulin Pumps Market - Strategic Deals Analysis 81
- 10.1 Key Deals, Insulin Pumps Market 81
- 10.1.1 Cellnovo Enters Into Technology Integration Agreement with LifeScan 81
- 10.1.2 Insulet Announced Acquisition of Neighborhood Diabetes 81
- 10.1.3 Insulet Entered into Distribution Agreement with GlaxoSmithKline 82
- 10.1.4 Cellnovo Entered into an Agreement with Home Diagnostics 82
- 10.1.5 Roche Holding Acquired Medingo from Elron Electronic Industries 82
- 10.1.6 JDRF Enters into an Agreement with Becton, Dickinson and Company 82
- 10.1.7 Insulet Enters into Distribution Agreement with Ypsomed Holding 83
11 Appendix 84
- 11.1 Market Definitions 85
- 11.2 Abbreviations (in alphabetical order) 85
- 11.3 Sources 86
- 11.4 Research Methodology 86
- 11.5 GlobalData Consulting 88
- 11.6 Contact Us 88
- 11.7 Disclaimer 88
List of Tables
1.1 List of Tables
- Table 1: Fasting Plasma Glucose Test 9
- Table 2: Oral Glucose Tolerance Test 9
- Table 3: Oral Glucose Tolerance Test for Gestational Diabetes 9
- Table 4: Diabetes Prevalence (%) and Patient Population, by Country, 2011 10
- Table 5: Insulin Pumps Market, Global, Revenue ($m), 2003-2010 14
- Table 6: Insulin Pumps Market, Global, Revenue ($m), 2010-2017 15
- Table 7: Organizations/Companies Developing Artificial Pancreas 18
- Table 8: Annual Increase in the Incidence of Diabetes Among Children in Europe, 1983-2005 20
- Table 9: Studies Indicating Safety and Efficacy of Insulin Pumps 22
- Table 10: Studies Indicating Safety and Efficacy of Insulin Pump Therapy in Pregnant Women, 2001-2011 23
- Table 11: Studies Suggesting Higher Risk of Ketoacidosis from Insulin Pump Use, 2004 & 2009 25
- Table 12: Traditional Insulin Pumps, Global, Revenue ($m), 2003-2010 27
- Table 13: Traditional Insulin Pumps, Global, Revenue ($m), 2010-2017 28
- Table 14: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income <$15000, June 2011 29
- Table 15: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $43,000, June 2011 30
- Table 16: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $75,000, June 2011 31
- Table 17: Disposable Insulin Pumps, Global, Revenue ($m), 2005-2010 33
- Table 18: Disposable Insulin Pumps, Global, Revenue ($m), 2010-2017 34
- Table 19: Insulin Pumps Market, The US, Revenue ($m), 2003-2010 36
- Table 20: Insulin Pumps Market, The US, Revenue ($m), 2010-2017 37
- Table 21: Insulin Pumps Market, Canada, Revenue ($m), 2003-2010 38
- Table 22: Insulin Pumps Market, Canada, Revenue ($m), 2010-2017 39
- Table 23: Insulin Pumps Market, The UK, Revenue ($m), 2003-2010 40
- Table 24: Insulin Pumps Market, The UK, Revenue ($m), 2010-2017 41
- Table 25: Insulin Pumps Market, Germany, Revenue ($m), 2003-2010 42
- Table 26: Insulin Pumps Market, Germany, Revenue ($m), 2010-2017 43
- Table 27: Insulin Pumps Market, France, Revenue ($m), 2003-2010 44
- Table 28: Insulin Pumps Market, France, Revenue ($m), 2010-2017 45
- Table 29: Insulin Pumps Market, Italy, Revenue ($m), 2003-2010 46
- Table 30: Insulin Pumps Market, Italy, Revenue ($m), 2010-2017 47
- Table 31: Insulin Pumps Market, Spain, Revenue ($m), 2003-2010 48
- Table 32: Insulin Pumps Market, Spain, Revenue ($m), 2010-2017 49
- Table 33: Insulin Pumps Market, Japan, Revenue ($m), 2003-2010 50
- Table 34: Insulin Pumps Market, Japan, Revenue ($m), 2010-2017 51
- Table 35: Insulin Pumps Market, China, Revenue ($m), 2003-2010 52
- Table 36: Insulin Pumps Market, China, Revenue ($m), 2010-2017 53
- Table 37: Insulin Pumps Market, India, Revenue ($m), 2003-2010 54
- Table 38: Insulin Pumps Market, India, Revenue ($m), 2010-2017 55
- Table 39: Insulin Pumps Market, Australia, Revenue ($m), 2003-2010 56
- Table 40: Insulin Pumps Market, Australia, Revenue ($m), 2010-2017 57
- Table 41: Insulin Pumps Market, Brazil, Revenue ($m), 2003-2010 58
- Table 42: Insulin Pumps Market, Brazil, Revenue ($m), 2010-2017 59
- Table 43: Insulin Pumps Market, Global, Key Company Revenues ($m), 2010 60
- Table 44: Pipeline Products, Medtronic Inc. 63
- Table 45: Key Products, Medtronic Inc. 64
- Table 46: Key Products, Insulet Corporation 66
- Table 47: Key Products, Disetronic Medical Systems AG 67
- Table 48: Pipeline Products, Animas Corporation 68
- Table 49: Key Products, Animas Corporation 69
- Table 50: Insulin Pumps, Pipeline by Phase of Development, 2011 70
- Table 51: Pipeline Products, Insulin Pumps 72
- Table 52: Artificial Pancreas System (Boston University), Clinical Trial Details 74
- Table 53: Artificial Pancreas System (University of Virginia), Clinical Trial Details 77
- Table 54: Key Deals, Insulin Pumps Market, 2009-2011 81
List of Figures
1.2 List of Figures
- Figure 1: Diabetes Prevalence (%), Global, 2011 10
- Figure 2: Insulin Pumps, Market Segmentation 12
- Figure 3: Comparison of Insulin Pumps with Other Insulin Delivery Devices 13
- Figure 4: Insulin Pumps Market, Global, Revenue ($m), 2003-2010 14
- Figure 5: Insulin Pumps Market, Global, Revenue ($m), 2010-2017 15
- Figure 6: Working of Artificial Pancreas 17
- Figure 7: Global Insulin Pumps, Market Dynamics 20
- Figure 8: Reasons for Type 1 Diabetes in Children 21
- Figure 9: Traditional Insulin Pumps, Global, Revenue ($m), 2003-2010 27
- Figure 10: Traditional Insulin Pumps, Global, Revenue ($m), 2010-2017 28
- Figure 11: Individual Out-of-Pocket Expenses for Diabetes Management in Canadian Provinces with Annual Income <$15,000, June 2011 29
- Figure 12: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $43,000, June 2011 30
- Figure 13: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $75,000, June 2011 31
- Figure 14: Disposable Insulin Pumps, Global, Revenue ($m), 2005-2010 33
- Figure 15: Disposable Insulin Pumps, Global, Revenue ($m), 2010-2017 34
- Figure 16: Insulin Pumps Market, The US, Revenue ($m), 2003-2010 36
- Figure 17: Insulin Pumps Market, The US, Revenue ($m), 2010-2017 37
- Figure 18: Insulin Pumps Market, Canada, Revenue ($m), 2003-2010 38
- Figure 19: Insulin Pumps Market, Canada, Revenue ($m), 2010-2017 39
- Figure 20: Insulin Pumps Market, The UK, Revenue ($m), 2003-2010 40
- Figure 21: Insulin Pumps Market, The UK, Revenue ($m), 2010-2017 41
- Figure 22: Insulin Pumps Market, Germany, Revenue ($m), 2003-2010 42
- Figure 23: Insulin Pumps Market, Germany, Revenue ($m), 2010-2017 43
- Figure 24: Insulin Pumps Market, France, Revenue ($m), 2003-2010 44
- Figure 25: Insulin Pumps Market, France, Revenue ($m), 2010-2017 45
- Figure 26: Insulin Pumps Market, Italy, Revenue ($m), 2003-2010 46
- Figure 27: Insulin Pumps Market, Italy, Revenue ($m), 2010-2017 47
- Figure 28: Insulin Pumps Market, Spain, Revenue ($m), 2003-2010 48
- Figure 29: Insulin Pumps Market, Spain, Revenue ($m), 2010-2017 49
- Figure 30: Insulin Pumps Market, Japan, Revenue ($m), 2003-2010 50
- Figure 31: Insulin Pumps Market, Japan, Revenue ($m), 2010-2017 51
- Figure 32: Insulin Pumps Market, China, Revenue ($m), 2003-2010 52
- Figure 33: Insulin Pumps Market, China, Revenue ($m), 2010-2017 53
- Figure 34: Insulin Pumps Market, India, Revenue ($m), 2003-2010 54
- Figure 35: Insulin Pumps Market, India, Revenue ($m), 2010-2017 55
- Figure 36: Insulin Pumps Market, Australia, Revenue ($m), 2003-2010 56
- Figure 37: Insulin Pumps Market, Australia, Revenue ($m), 2010-2017 57
- Figure 38: Insulin Pumps Market, Brazil, Revenue ($m), 2003-2010 58
- Figure 39: Insulin Pumps Market, Brazil, Revenue ($m), 2010-2017 59
- Figure 40: Insulin Pumps Market, Global, Key Company Shares (%), 2010 60
- Figure 41: Insulin Pumps Market, Competitive Assessment 61
- Figure 42: Insulin Pumps, Pipeline by Phase of Development, 2011 70
- Figure 43: Pipeline Assessment by Developmental Stage, 2011 71
胰島素幫浦市場－償還和臨床試驗數據牽引成長
2011年12月15日
Global Information, Inc.已開始銷售GlobalData所發行的報告書「Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 (全球胰島素幫浦市場:開發平台分析，競爭環境，到2017年為止的市場預測)」
糖尿病的高發病率是胰島素幫浦市場擴大的主因
GLOBALDATA推測2010年全球的胰島素幫浦市場是7億2,590萬美元規模。
該市場預計以複合年成長率(CAGR)7.8％擴大，2017年時將達到12億美元規模。
糖尿病發病症比率劇增，尤其是兒童胰島素依賴性糖尿病的發病率上升，以及成為保險償還的對象，胰島素幫浦積極使用的臨床轉換期，預料對特定患者族群之胰島素幫浦的優點等，將牽引胰島素幫浦市場。
諸多研究指出不滿18歲的兒童糖尿病發病率劇增。
依據EURODIAB實施、2009年6月在醫學雜誌The Lancet發表的研究，歐洲不滿15歲兒童的1型糖尿病發病率，預計將從2005年的9萬4,000人到2020年時增加為16萬人。
2010年全球糖尿病的患者數推定為2億8,500萬人，依據現在的增加率，預估2030年之前將上升到4億3,800萬人。
|
 |
